Vitamin A in cord blood for premature babies
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study looks at vitamin A levels in cord blood (blood from the umbilical cord after birth) and how they relate to health outcomes for babies born very early (before 32 weeks). Participating may help researchers understand if vitamin A affects prematurity complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born before 32 weeks of pregnancy.
- Your baby must be born at the First Hospital of Jilin University.
- A sample of umbilical cord blood must be collected within 24 hours of birth.
- You and your partner must agree to sign a consent form.
- Your baby must not have major birth defects or chromosomal problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether red blood cells made from donated cord blood are safe and effective for very premature babies who need a transfusion. It may offer an alternative to standard donor blood for these fragile infants.
This study looks at vitamin D levels in a newborn's umbilical cord blood to understand what affects them and whether they relate to health outcomes. It uses leftover blood from routine delivery and involves no extra procedures.
This study tests whether taking a vitamin A supplement while you are breastfeeding can increase the amount of vitamin A in your breast milk. Vitamin A is important for your preterm baby's growth and development, and this trial aims to see if it helps.
This study tests whether using cord blood (the blood left in the umbilical cord after birth) that is rich in fetal hemoglobin (the type of hemoglobin babies have before birth) can make blood transfusions safer and more personalized for very premature babies. If this works, it might reduce the need for multiple transfusions and improve outcomes for preterm infants.
This study looks at microscopic particles called extracellular vesicles in the umbilical cord blood of babies born before 28 weeks. Researchers want to see if these particles can help predict severe health problems or death, and eventually improve care for extremely premature newborns.
This study looks at levels of B vitamins in babies born early (before 37 weeks). It aims to see if current vitamin supplements are enough for preterm babies, which might help improve their nutrition and growth.
Hear when a new Extremely Premature Infant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.